204 related articles for article (PubMed ID: 34779884)
1. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging.
Wakileh GA; Ruf C; Heidenreich A; Dieckmann KP; Lisson C; Prasad V; Bolenz C; Zengerling F
World J Urol; 2022 Feb; 40(2):307-315. PubMed ID: 34779884
[TBL] [Abstract][Full Text] [Related]
2. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Joice GA; Rowe SP; Gorin MA; Pierorazio PM
Curr Urol Rep; 2018 Nov; 19(12):110. PubMed ID: 30413968
[TBL] [Abstract][Full Text] [Related]
4. Testicular Germ Cell Tumors: Classification, Pathologic Features, Imaging Findings, and Management.
Katabathina VS; Vargas-Zapata D; Monge RA; Nazarullah A; Ganeshan D; Tammisetti V; Prasad SR
Radiographics; 2021 Oct; 41(6):1698-1716. PubMed ID: 34597218
[TBL] [Abstract][Full Text] [Related]
5. [Positron emission tomography in germ cell tumors in men : Possibilities and limitations].
Schriefer P; Hartmann M; Oechsle K; Meyer CP; Klutmann S; Fisch M; Bokemeyer C; Oing C
Urologe A; 2019 Apr; 58(4):418-423. PubMed ID: 30374517
[TBL] [Abstract][Full Text] [Related]
6. Performance Characteristics of Clinical Staging Modalities for Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Tema G; Patel HD; Gupta M; Sharma R; Zhang A; Bass EB
J Urol; 2020 May; 203(5):894-901. PubMed ID: 31609176
[TBL] [Abstract][Full Text] [Related]
7. PET imaging in the management of tumors of testis and ovary: current thinking and future directions.
Basu S; Rubello D
Minerva Endocrinol; 2008 Sep; 33(3):229-56. PubMed ID: 18846028
[TBL] [Abstract][Full Text] [Related]
8. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Rasheed R; Al-Kandari F; Ghanem M; Marafi F; Usmani S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):511-515. PubMed ID: 32102532
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters.
Aydos U; Tahtaci G; Özgür Akdemir Ü; Özet A
Nucl Med Commun; 2020 Nov; 41(11):1199-1209. PubMed ID: 32796455
[TBL] [Abstract][Full Text] [Related]
10. The role of
Hung TJ; McLean L; Mitchell C; Pascoe C; Lawrentschuk N; Murphy DG; Iravani A; Singh D; Hofman MS; Zidan L; Akhurst T; Lewin J; Hicks RJ
Cancer Imaging; 2019 May; 19(1):28. PubMed ID: 31142361
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. PET in testicular cancer.
Becherer A
Methods Mol Biol; 2011; 727():225-41. PubMed ID: 21331937
[TBL] [Abstract][Full Text] [Related]
13. The potential role of MR based radiomic biomarkers in the characterization of focal testicular lesions.
Feliciani G; Mellini L; Carnevale A; Sarnelli A; Menghi E; Piccinini F; Scarpi E; Loi E; Galeotti R; Giganti M; Parenti GC
Sci Rep; 2021 Feb; 11(1):3456. PubMed ID: 33568713
[TBL] [Abstract][Full Text] [Related]
14. Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors.
Saidian A; Bagrodia A
Curr Urol Rep; 2023 Sep; 24(9):451-454. PubMed ID: 37368095
[TBL] [Abstract][Full Text] [Related]
15. [Importance of pathology for therapy planning of testicular germ cell tumors].
Heidenreich A; Knüchel-Clarke R; Pfister D
Pathologe; 2014 May; 35(3):266-73. PubMed ID: 24771259
[TBL] [Abstract][Full Text] [Related]
16. An annotated T2-weighted magnetic resonance image collection of testicular germ and non-germ cell tumors.
Feliciani G; Mellini L; Loi E; Piccinini F; Galeotti R; Sarnelli A; Parenti GC
Sci Data; 2021 Aug; 8(1):209. PubMed ID: 34354085
[TBL] [Abstract][Full Text] [Related]
17. Imaging of testicular germ cell tumours.
Dalal PU; Sohaib SA; Huddart R
Cancer Imaging; 2006 Sep; 6(1):124-34. PubMed ID: 16966068
[TBL] [Abstract][Full Text] [Related]
18. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.
de Wit M; Brenner W; Hartmann M; Kotzerke J; Hellwig D; Lehmann J; Franzius C; Kliesch S; Schlemmer M; Tatsch K; Heicappell R; Geworski L; Amthauer H; Dohmen BM; Schirrmeister H; Cremerius U; Bokemeyer C; Bares R
Ann Oncol; 2008 Sep; 19(9):1619-23. PubMed ID: 18453520
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
Zhao JY; Ma XL; Li YY; Zhang BL; Li MM; Ma XL; Liu L
Asian Pac J Cancer Prev; 2014; 15(8):3525-31. PubMed ID: 24870751
[TBL] [Abstract][Full Text] [Related]
20. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
